⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3065839 | 0.97 | PAOX (0.64) | — | |
| SCHEMBL944344 | 0.97 | PAOX (0.64) | — | |
| SCHEMBL7007901 | 0.97 | PAOX (0.64) | — | |
| SCHEMBL1389554 | 0.97 | PAOX (0.64) | — | |
| SCHEMBL7010487 | 0.97 | PAOX (0.64) | — | |
| SCHEMBL16247098 | 0.97 | PAOX (0.64) | — | |
| SCHEMBL7010157 | 0.97 | PAOX (0.64) | — | |
| SCHEMBL7004889 | 0.97 | PAOX (0.64) | — | |
| Hydrochloric Acid SCHEMBL4147468 | 0.97 | PAOX (0.58) | — | |
| Hydrochloric Acid SCHEMBL25353689 | 0.95 | PAOX (0.61) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 387 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114231551-B | Application of protein in promoting apoptosis of insect lymphocytes and/or preventing and controlling pests | 云南大学 | 2023-09-29 | — | — | CN | claimed |
| CN-114231551-A | Application of protein in promoting apoptosis of insect lymphocyte and/or preventing and treating pests | 云南大学 | 2022-03-25 | — | — | CN | claimed |
| WO-2021217040-A1 | CARBAMATE AND UREA DERIVATIVES | IMMVENTION THERAPEUTIX (US) | 2021-10-28 | — | — | WO | claimed |
| EP-3686182-A1 | CHEMICALLY ACTIVATED WATER-SOLUBLE PRODRUG | Sumitomo Dainippon Pharma Co., Ltd. (JP) | 2020-07-29 | — | — | EP | claimed |
| US-20200207782-A1 | CHEMICALLY ACTIVATED WATER-SOLUBLE PRODRUG | SUMITOMO DAINIPPON PHARMA CO., LTD (JP) | 2020-07-02 | — | — | US | claimed |
| CN-105985944-B | A kind of new method of intracellular site specific covalent labeled RNA | 中国科学院生物物理研究所 | 2019-05-28 | — | — | CN | claimed |
| WO-2026088120-A1 | LIPIDATED TLR7/8 MODULATORS AS ADJUVANTS AND USES THEREOF | PFIZER INC. (US) | 2026-04-30 | — | — | WO | disclosed |
| WO-2025096856-A1 | COVALENT CEREBLON LIGANDS | C4 THERAPEUTICS, INC. (US) | 2025-05-08 | — | — | WO | disclosed |
| CN-119899265-A | High affinity nanobodies targeting B7H3 (CD 276) for the treatment of multiple solid tumors | 美国政府(由卫生和人类服务部的部长所代表) | 2025-04-29 | — | — | CN | disclosed |
| CN-114729041-B | High affinity nanobodies targeting B7H3 (CD 276) for the treatment of multiple solid tumors | 美国政府(由卫生和人类服务部的部长所代表) | 2024-12-31 | — | — | CN | disclosed |
| US-20240226343-A1 | NEUROPEPTIDE Y1 RECEPTOR (NPY1R) TARGETED THERAPEUTICS AND USES THEREOF | RADIONETICS ONCOLOGY, INC. | 2024-07-11 | — | — | US | disclosed |
| WO-2024147060-A1 | NOVEL IONIZABLE LIPID COMPOUNDS FOR NUCLEIC ACID DELIVERY | CELON PHARMA S.A. (PL) | 2024-07-11 | — | — | WO | disclosed |
| WO-2024133853-A1 | BIS-ESTER AND AMIDE CATIONIC LIPIDS | SANOFI (FR) | 2024-06-27 | — | — | WO | disclosed |
| EP-1348710-A1 | Sulfonamide derivatives of 3-substituted imidazo[1,2-D]-1,2,4-thiadiazoles and 3-substituted-[1,2,4]thiadiazolo[4,5-A]benzimidazole as inhibitors of fibrin cross-linking and transglutaminases | Apotex Inc. (CA) | 2003-10-01 | — | — | EP | disclosed |
| US-5741799-A | ANTICOAGULANTS OF SULFONAMIDO HETEROCYCLIC THROMBIN INHIBITORS | BRISTOL-MYERS SQUIBB COMPANY (US) | 1998-04-21 | — | — | US | disclosed |
| US-5741792-A | ANTICOAGULANTS OF SULFONAMIDO HETEROCYCLIC THROMBIN INHIBITORS | BRISTOL-MYERS SQUIBB COMPANY (US) | 1998-04-21 | — | — | US | disclosed |
| US-5583146-A | Heterocyclic thrombin inhibitors | BRISTOL-MYERS SQUIBB COMPANY (US) | 1996-12-10 | — | — | US | disclosed |
| US-5350864-A | Aminoalkylcarbamyl derivatives of forskolin as intermediates for the synthesis of useful forskolin derivatives | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 1994-09-27 | — | — | US | disclosed |
| EP-0601459-A2 | Sulfonamido heterocyclic thrombin inhibitors | BRISTOL-MYERS SQUIBB COMPANY (US) | 1994-06-15 | — | — | EP | disclosed |
| WO-1991017154-A1 | AMINOALKYLCARBAMYL DERIVATIVES OF FORSKOLIN AS INTERMEDIATES FOR THE SYNTHESIS OF USEFUL FORSKOLIN DERIVATIVES | THE UNITED STATES OF AMERICA, REPRESENTED BY THE SECRETARY, UNITED STATES DEPARTMENT OF COMMERCE (US) | 1991-11-14 | — | — | WO | disclosed |